A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to assess the safety and tolerability of BMS-986525 alone and in combination with Pumitamig in participants with Relapsed/Refractory Small Cell Lung Cancer
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony histologicznie lub cytologicznie nawrotowy lub oporny na leczenie rak płuca o małych komórkach
- •Wcześniejsze leczenie chemioterapią opartą na związkach platyny (co najmniej jeden schemat)
- •W krajach gdzie standardowe leczenie pierwszego rzędu obejmuje chemioterapię z platynią w połączeniu z immunoterapią, pacjent musi wykazać progresję, nie kwalifikować się lub nie mieć dostępu do tego leczenia
✗ Disqualifies
- •Niepowstrzymane przerzuty do mózgu
- •Aktywna choroba autoimmunologiczna
- •Wcześniejszy przeszczep organu lub tkanki
- •Inne kryteria określone w protokole badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (12)
Karmanos Cancer Institute
Detroit, United States
Local Institution - 0026
Buffalo, United States
Duke Cancer Institute
Durham, United States
University Hospitals Cleveland Medical Center
Cleveland, United States
SCRI Oncology Partners
Nashville, United States
Local Institution - 0028
Shanghai Shi, China
Istituto Clinico Humanitas
Rozzano, Italy
Local Institution - 0020
Hirakata, Japan
Local Institution - 0018
Chuo-ku, Japan
Oncohelp Medical Center
Timișoara, Romania
Local Institution - 0003
Craiova, Romania
Local Institution - 0009
Madrid, Spain
Trial contact
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
First line of the email MUST contain NCT # and Site #.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.